Impact of Continuation Versus Interruption of Oral Anticoagulation During TAVI on Health‐Related Quality of Life
In patients undergoing TAVR with a concomitant indication for oral anticoagulation, continuation as compared to interruption of oral anticoagulation during TAVR did not significantly impact health-related quality of life up to 3 months after TAVR.
Authors
- Leo Veenstra
- Jurriën M. ten Berg (ORCID: https://orcid.org/0000-0001-5192-886X)
- Ole De Backer (ORCID: https://orcid.org/0000-0002-9674-0278)
- Liesbeth Rosseel (ORCID: https://orcid.org/0000-0002-3940-3072)
- Christophe Dubois (ORCID: https://orcid.org/0000-0003-2421-6087)
- Hugo M. Aarts (ORCID: https://orcid.org/0000-0003-0852-8275)
- Maxim J P Rooijakkers (ORCID: https://orcid.org/0000-0002-6815-7667)
- Willem L. Bor (ORCID: https://orcid.org/0000-0002-3253-5961)
- Ronak Delewi (ORCID: https://orcid.org/0000-0001-6070-9423)
- Dirk Jan van Ginkel
Institutions
- Radboud University Nijmegen (NL)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Hart voor Research Aalst (BE)
- St. Antonius Ziekenhuis (NL)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1002/ccd.31457
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00